Balance Labs Stock Performance
| BLNC Stock | USD 1.55 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Balance Labs are expected to decrease at a much lower rate. During the bear market, Balance Labs is likely to outperform the market. At this point, Balance Labs has a negative expected return of -0.37%. Please make sure to confirm Balance Labs' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Balance Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Balance Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 5632.00 | |
| Total Cashflows From Investing Activities | -203.7 K |
Balance |
Balance Labs Relative Risk vs. Return Landscape
If you would invest 200.00 in Balance Labs on October 31, 2025 and sell it today you would lose (45.00) from holding Balance Labs or give up 22.5% of portfolio value over 90 days. Balance Labs is currently does not generate positive expected returns and assumes 2.7326% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of pink sheets are less volatile than Balance, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Balance Labs Target Price Odds to finish over Current Price
The tendency of Balance Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.55 | 90 days | 1.55 | about 64.62 |
Based on a normal probability distribution, the odds of Balance Labs to move above the current price in 90 days from now is about 64.62 (This Balance Labs probability density function shows the probability of Balance Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Balance Labs has a beta of -0.12 suggesting as returns on the benchmark increase, returns on holding Balance Labs are expected to decrease at a much lower rate. During a bear market, however, Balance Labs is likely to outperform the market. Additionally Balance Labs has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Balance Labs Price Density |
| Price |
Predictive Modules for Balance Labs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Balance Labs. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Balance Labs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Balance Labs is not an exception. The market had few large corrections towards the Balance Labs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Balance Labs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Balance Labs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | -0.12 | |
σ | Overall volatility | 0.16 | |
Ir | Information ratio | -0.2 |
Balance Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Balance Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Balance Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Balance Labs generated a negative expected return over the last 90 days | |
| Balance Labs may become a speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
Balance Labs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Balance Pink Sheet often depends not only on the future outlook of the current and potential Balance Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Balance Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.7 M | |
| Cash And Short Term Investments | 227.6 K |
Balance Labs Fundamentals Growth
Balance Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Balance Labs, and Balance Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Balance Pink Sheet performance.
| Return On Asset | 0.0771 | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 7.28 M | |||
| Shares Outstanding | 21.67 M | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 79.24 X | |||
| Price To Sales | 8.12 X | |||
| Revenue | 624.59 K | |||
| EBITDA | (552.39 K) | |||
| Cash And Equivalents | 227.77 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 468.81 K | |||
| Book Value Per Share | (0.18) X | |||
| Cash Flow From Operations | (56) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 1.01 M | |||
| Retained Earnings | (1.09 M) | |||
| Current Asset | 205 K | |||
| Current Liabilities | 552 K | |||
About Balance Labs Performance
By analyzing Balance Labs' fundamental ratios, stakeholders can gain valuable insights into Balance Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Balance Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Balance Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company was incorporated in 2014 and is based in Miami Beach, Florida. Balance Labs operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Balance Labs performance evaluation
Checking the ongoing alerts about Balance Labs for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Balance Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Balance Labs generated a negative expected return over the last 90 days | |
| Balance Labs may become a speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
- Analyzing Balance Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Balance Labs' stock is overvalued or undervalued compared to its peers.
- Examining Balance Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Balance Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Balance Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Balance Labs' pink sheet. These opinions can provide insight into Balance Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Balance Pink Sheet analysis
When running Balance Labs' price analysis, check to measure Balance Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balance Labs is operating at the current time. Most of Balance Labs' value examination focuses on studying past and present price action to predict the probability of Balance Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balance Labs' price. Additionally, you may evaluate how the addition of Balance Labs to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |